Skip to main content
. 2023 May 30;14:1192999. doi: 10.3389/fphar.2023.1192999

TABLE 3.

Combination index (CI) value of a two-drug combination between resveratrol, and other antibabesial drugs on the in vitro growth of B. bovis, B. bigemina, and T. equi.

Drug combinations a CI value at Weighted average CI values b Degree of synergism c
IC50 IC75 IC90 IC95
Diminazene aceturate
 B. bovis >10 >10 >10 10.21 >10 Antagonism
 B. bigemina 13.12 10.29 8.08 6.86 9.58 Antagonism
 T. equi >10 >10 7.67 3.13 >10 Antagonism
Imidocarb dipropionate
 B. bovis >10 >10 >10 >10 >10 Antagonism
 B. bigemina >10 >10 >10 >10 >10 Antagonism
 T. equi 0.11 0.24 14.62 8.74 5.92 Antagonism
MMV396693
 B. bovis >10 >10 >10 >10 >10 Antagonism
 B. bigemina >10 >10 >10 >10 >10 Antagonism
 T. equi >10 >10 >10 >10 >10 Antagonism

CI, value, combination index value; IC50, 50% inhibition concentration.

a

Two-drug combination between resveratrol, and other antibabesial drugs at a concentration of approximately 0.25 x IC50, 0.5 x IC50, IC50, 2 x IC50 and 4 x IC50 (constant ratio).

b

The higher inhibition is preferable; thus, the weighted average CI, value was calculated with the formula [(1 x IC50) + (2 x IC75) + (3 x IC90) + (4 x IC95)]/10.

c

The degree of synergism was determined based on the Chou-Talalay method.